Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 70 M72 M72 M74 M72 M73 M 291 M Research & development —————— — Operating income 1.52 B1.53 B1.65 B1.62 B1.65 B1.66 B 6.57 B Non-Operating Income, Total 60 M-47 M14 M15 M36 M-27 M 38 M Interest expense, net of interest capitalized 531 M525 M539 M487 M454 M471 M 1.95 B Non-Operating Income, excl. Interest Expenses -471 M-572 M-525 M-472 M-418 M-498 M -1.91 B Unusual income/expense —————— — Pretax income 621 M706 M708 M708 M714 M718 M 2.85 B Equity in earnings —————— — Taxes 131 M143 M139 M174 M155 M148 M 616 M Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations 490 M563 M569 M534 M559 M570 M 2.23 B Discontinued operations —————— — Net income 490 M563 M569 M534 M559 M570 M 2.23 B Dilution adjustment 000000 0 Preferred dividends 25 M29 M21 M20 M20 M21 M 82 M Diluted net income available to common stockholders 465 M534 M548 M514 M539 M549 M 2.15 B Basic earnings per share (Basic EPS) 0.510.590.620.590.630.64 2.48 Diluted earnings per share (Diluted EPS) 0.510.590.610.590.620.64 2.46 Average basic shares outstanding 906 M898 M890 M892 M863 M854 M — Diluted shares outstanding 910 M900 M894 M896 M868 M857 M — EBITDA —————— — EBIT 991 M1 B1.11 B1.13 B1.19 B1.19 B 4.62 B Cost of revenue 124 M126 M105 M115 M91 M68 M 379 M Other cost of goods sold —————— — Depreciation & amortization (cash flow) —————— —